Agenda and supporting papers - Plymouth Hospitals NHS Trust
Agenda and supporting papers - Plymouth Hospitals NHS Trust
Agenda and supporting papers - Plymouth Hospitals NHS Trust
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Item 3<br />
medical appraisal was complete <strong>and</strong> he expected to bring a proposal<br />
to the Senior Management Team to review in July. The Board<br />
discussed the inclusion in appraisal documentation of key clinical<br />
competencies by staff grade. Mr Bamber stated that the <strong>Trust</strong> applied<br />
the <strong>Agenda</strong> for Change Knowledge <strong>and</strong> Skills Framework but Mr Dix<br />
acknowledged that the identification of key clinical competencies<br />
across all wards <strong>and</strong> specialties was inconsistent. There was<br />
agreement that the broader issue was for appraisal documentation to<br />
facilitate the alignment of personal objectives with <strong>Trust</strong> objectives.<br />
D<br />
The twelve month average sickness absence rate had reduced to<br />
4.49%. Focus on progress towards achieving the <strong>Trust</strong> target of 3.8%<br />
was being applied through robust management, with additional<br />
training for managers.<br />
R<br />
Monitor’s Governance Risk Rating<br />
The Board noted the RAG rating of red for April. Professor Lewis<br />
queried the underlying reason for failing the cancer screening service<br />
referral <strong>and</strong> Mr Baber would provide this information outside the<br />
meeting.<br />
A<br />
In concluding the Board’s discussions, it was agreed that the Senior<br />
Management Team would review the presentation <strong>and</strong> content of the<br />
performance narrative to ensure that it provided oversight of KPIs<br />
associated with the implementation of the Winter Plan, the Annual<br />
Business Plan <strong>and</strong> the Board-specific KPIs agreed earlier in the year.<br />
F<br />
The Board noted the Performance Report.<br />
110/13 Infection Prevention <strong>and</strong> Control Annual Report 2012/13<br />
Dr Peter Jenks, Director of Infection Prevention <strong>and</strong> Control, <strong>and</strong> Ms<br />
Claire Haill, Lead Nurse<br />
T<br />
Infection Control, attended for this item.<br />
Dr Jenks presented highlights from his report <strong>and</strong> drew the Board’s<br />
attention to key achievements in 2012/13. Overall, he was pleased to<br />
report a significantly improved position since he was last invited to<br />
report to the Board in September 2012. He acknowledged the<br />
contribution of the Chief Executive in this regard, <strong>and</strong> of Julie<br />
Richards, Associate Director of Planning, <strong>and</strong> Stuart Windsor, Facility<br />
Operations Manager in their work with Serco. Looking forward, new<br />
<strong>and</strong> inexperienced staff would be joining the <strong>Trust</strong> in the next few<br />
weeks <strong>and</strong> the infection control team must prepare for their arrival <strong>and</strong><br />
continue to lead on minimising infections associated with medical<br />
devices.<br />
COO<br />
SMT<br />
The Chairman asked how the <strong>Trust</strong> could ensure a consistently<br />
rigorous focus on infection control. Dr Jenks suggested encouraging<br />
a culture keen to demonstrate best practice. Mr Dix agreed; the nurse<br />
preceptorship period was vital in embedding best practice <strong>and</strong><br />
<strong>supporting</strong> relevant training. Noting the number of bed days lost due<br />
11